Narjust Florez
MD
Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
May 12, 2023
Episode
158
Soundcloud
Share
In this episode of Lung Cancer Considered, host Dr. Narjust Florez discusses ROS+1 Fusions in NSCLC, including diagnosis, treatment, and new exciting research coming down the pipeline.
Guest
Shirish Gadgeel
MD
Chief, Division of Hematology and Oncology, Department of Internal Medicine
Henry Ford Cancer Institute
Henry Ford Health System
Lorenza Landi
MD
Director of Clinical Trials Unit: Phase 1 and Precision Medicine
National Cancer Institute Regina Elena in Rome
